Literature DB >> 8386700

Angiotensin II facilitates sympathetic transmission in rat hind limb circulation.

K F Hilgers1, R Veelken, G Rupprecht, P W Reeh, F C Luft, J F Mann.   

Abstract

We developed a novel method to stimulate the sympathetic innervation of the isolated, perfused rat hind limb to investigate whether a subpressor concentration of angiotensin II (Ang II) facilitates noradrenergic transmission in the vascular bed to skeletal muscle. We electrically stimulated the lumbar sympathetic trunk while perfusing the preparation with artificial medium. Seventy-five percent of the resulting frequency-dependent increases in perfusion pressure were mediated by alpha 1-adrenergic receptors. Ang II (10 nM) significantly enhanced the effects of nerve stimulation at 1 and 10 Hz (by 42% and 35%, respectively). At a supramaximal stimulation frequency (20 Hz), Ang II prolonged the duration of the response without changing the peak increase in pressure. The reuptake inhibitor cocaine did not influence the effects of Ang II at 1 and 10 Hz but blocked the effect at 20 Hz. To control for nonspecific synergism with norepinephrine, we compared Ang II with vasopressin. Both peptides potentiated the pressor response to exogenous norepinephrine; however, vasopressin did not change the pressor response to nerve stimulation at any frequency. We conclude that Ang II, but not vasopressin, facilitates noradrenergic transmission in skeletal muscle resistance vessels, independent of its direct vasoconstrictor activity. The neurovascular preparation we describe may be useful in addressing other hypotheses concerning sympathetic transmission in skeletal muscle resistance vessels.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386700     DOI: 10.1161/01.hyp.21.3.322

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

Review 1.  The control of adrenergic function in heart failure: therapeutic intervention.

Authors:  A L Clark; J G Cleland
Journal:  Heart Fail Rev       Date:  2000-03       Impact factor: 4.214

2.  Involvement of nitric oxide, but not prostaglandins, in the vascular sympathoinhibitory effects of losartan in the pithed spontaneously hypertensive rat.

Authors:  C Richer; V Domergue; M P Vincent; J F Giudicelli
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

3.  Modulation by the endothelium of sympathetic vasoconstriction in an in vitro preparation of the rat tail artery.

Authors:  E Thorin; J Atkinson
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

4.  Angiotensin II formation in the intact human heart. Predominance of the angiotensin-converting enzyme pathway.

Authors:  L S Zisman; W T Abraham; G E Meixell; B N Vamvakias; R A Quaife; B D Lowes; R L Roden; S J Peacock; B M Groves; M V Raynolds
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

5.  Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm.

Authors:  B Clemson; L Gaul; S S Gubin; D M Campsey; J McConville; J Nussberger; R Zelis
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

6.  Post-exercise reduction in blood pressure in hypertensive subjects: effects of angiotensin converting enzyme inhibition.

Authors:  M Beaulieu; A Nadeau; Y Lacourcière; J Cléroux
Journal:  Br J Clin Pharmacol       Date:  1993-10       Impact factor: 4.335

7.  Angiotensin peptide synthesis and cyclic nucleotide modulation in sympathetic stellate ganglia.

Authors:  Emma N Bardsley; Oliver C Neely; David J Paterson
Journal:  J Mol Cell Cardiol       Date:  2019-12-10       Impact factor: 5.000

Review 8.  Neurocardiac regulation: from cardiac mechanisms to novel therapeutic approaches.

Authors:  E N Bardsley; D J Paterson
Journal:  J Physiol       Date:  2018-11-12       Impact factor: 5.182

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.